Reproductive Health Experiences of Females Diagnosed with Young-Onset Colorectal Cancer: A Multi-Method Cross-Sectional Survey.


Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
21 01 2022
Historique:
received: 02 12 2021
revised: 12 01 2022
accepted: 15 01 2022
entrez: 24 2 2022
pubmed: 25 2 2022
medline: 25 3 2022
Statut: epublish

Résumé

Given the increasing risk of young-onset colorectal cancer (yCRC) among adults under 50 years, it is important to understand impacts on reproductive health. Our objective was to assess experiences with reproductive health after yCRC diagnosis among females. We conducted a cross-sectional study among females, 18 years or older, who have been diagnosed yCRC and are able to communicate in English. Data were gathered using an online survey involving both quantitative (e.g., multiple choice) and qualitative (e.g., open-ended text) questions on pregnancy history, influence of yCRC on reproductive decisions, and experiences with reproductive healthcare. Altogether, 101 females with yCRC participated, including 23 who had never been pregnant and 78 who had been pregnant. yCRC influenced family planning goals for one-third of participants. Furthermore, compared to participants who completed treatment, those currently undergoing treatment had higher odds of indicating their yCRC diagnosis influenced family planning goals (adjusted odds ratio 4.93; 95% confidence interval 1.29 to 18.78). Although 53 (52.5%) participants indicated having discussions regarding reproductive health with healthcare provider(s), 44 (43.6%) did not. Content analysis of open-ended survey questions identified themes on the emotional impacts, experiences with reproductive healthcare, reproductive and family planning considerations, and the related issue of sexual health impacts of yCRC. Gaps in care, related to limited reproductive health discussions, influence of yCRC on family planning, and experiencing lasting reproductive health impacts highlight the need for improving reproductive healthcare, particularly for females diagnosed with yCRC.

Identifiants

pubmed: 35200542
pii: curroncol29020042
doi: 10.3390/curroncol29020042
pmc: PMC8870126
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

465-478

Subventions

Organisme : CIHR
ID : PJT-159467
Pays : Canada

Références

J Natl Cancer Inst. 2017 Aug 1;109(8):
pubmed: 28376186
Eur J Gastroenterol Hepatol. 2017 Jul;29(7):743-753
pubmed: 28252463
JAMA Surg. 2015 Jan;150(1):17-22
pubmed: 25372703
Hum Reprod Update. 2001 Nov-Dec;7(6):535-43
pubmed: 11727861
Cancer. 2016 Jul 1;122(13):2101-9
pubmed: 27213483
Patient Educ Couns. 2016 Nov;99(11):1814-1820
pubmed: 27387120
Patient Educ Couns. 2019 Mar;102(3):436-442
pubmed: 30314828
BMC Cancer. 2020 Oct 27;20(1):1031
pubmed: 33109114
Cancer. 2016 Mar 15;122(6):929-34
pubmed: 26808454
J Adv Nurs. 2008 Apr;62(1):107-15
pubmed: 18352969
Dis Colon Rectum. 2011 Mar;54(3):363-9
pubmed: 21304311
CA Cancer J Clin. 1997 Jan-Feb;47(1):5-27
pubmed: 8996076
J Cancer Surviv. 2021 Mar 11;:
pubmed: 33709303
Cureus. 2017 Apr 25;9(4):e1190
pubmed: 28553568
Case Rep Obstet Gynecol. 2013;2013:626393
pubmed: 23401815
BMC Cancer. 2020 Apr 6;20(1):288
pubmed: 32252672
Support Care Cancer. 2020 Dec;28(12):6011-6021
pubmed: 32296980
Fam Pract. 2015 Aug;32(4):387-94
pubmed: 25977134
Arch Intern Med. 2012 Feb 13;172(3):287-9
pubmed: 22157065
Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1695-8
pubmed: 19505901
Case Rep Gastroenterol. 2019 Jun 13;13(2):253-257
pubmed: 31275088

Auteurs

Louise Araujo (L)

Faculty of Pharmaceutical Sciences, University of British Columbia, 2405 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.
Collaboration for Outcomes Research and Evaluation, Vancouver, BC V6T 1Z3, Canada.

Nevena Rebic (N)

Faculty of Pharmaceutical Sciences, University of British Columbia, 2405 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.
Collaboration for Outcomes Research and Evaluation, Vancouver, BC V6T 1Z3, Canada.

Hallie Dau (H)

Faculty of Pharmaceutical Sciences, University of British Columbia, 2405 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.
Collaboration for Outcomes Research and Evaluation, Vancouver, BC V6T 1Z3, Canada.

Lori Brotto (L)

Department of Obstetrics and Gynaecology, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.

Manju George (M)

COLONTOWN®, Paltown Development Foundation 969 Diggs Road, Crownsville, MD 21032, USA.

Mary A De Vera (MA)

Faculty of Pharmaceutical Sciences, University of British Columbia, 2405 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.
Collaboration for Outcomes Research and Evaluation, Vancouver, BC V6T 1Z3, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH